# Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound

Study · id `cardio:ct-nct01043380` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01043380](<https://clinicaltrials.gov/study/NCT01043380>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01043380

Browse, organ or system: Heart; Metabolism  
Browse, condition area: Risk and prevention; Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 245 participants.

## Technical summary

Registry record NCT01043380. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2014-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 245 participants (enrolled count; ClinicalTrials.gov record NCT01043380, source copy `cardio:ctgov-nct01043380-2015-04-01`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT01043380, source copy `cardio:ctgov-nct01043380-2015-04-01`, retrieved 2026-10-26)
- Primary completion: 2014-03 (actual) (ClinicalTrials.gov record NCT01043380, source copy `cardio:ctgov-nct01043380-2015-04-01`, retrieved 2026-10-26)
- Completion: 2014-09 (actual) (ClinicalTrials.gov record NCT01043380, source copy `cardio:ctgov-nct01043380-2015-04-01`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01043380, source copy `cardio:ctgov-nct01043380-2015-04-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01043380-2015-04-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound
- Acronym: PRECISE-IVUS
- Condition: Hypercholesterolemia
- Condition: Coronary Artery Disease
- Intervention (Drug): Combination therapy with Lipitor \[Atorvastatin\] and Zetia \[Ezetimibe\]
- Intervention (Drug): Lipitor (Atorvastatin) monotherapy
- Lead sponsor: Kumamoto University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial (`cardio:pubmed-26227186`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Lipid profile associated with coronary plaque regression in patients with acute coronary syndrome: Subanalysis of PRECISE-IVUS trial (`cardio:pubmed-27318866`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of statin-ezetimibe combination on coronary atheroma plaque in patients with and without chronic kidney disease - Sub-analysis of PRECISE-IVUS trial (`cardio:pubmed-29925472`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3565e0e30126a9217e07563cdcbfd71300e7ec47131c7c08ec2bc8da98745b71
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
